ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
501 | 49.91599 | 1 | male | 1 | 20 | 20 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | >$50k | 26 | 220,490 | 101,904.875 | null | 36 | black | 26.796875 | 25 | 0.515991 | 0.399963 | 19 | 0 | 0 | metastatic | 0.1 | 0.001 | dnr after sadm | 5 | 115 | 15 | 55 | 14 | 36.09375 | 136.65625 | 2 | 1 | 0.599976 | 136 | 7.5 | null | null | null | null | null | <2 mo. follow-up | 3.306152 |
502 | 51.56699 | 0 | female | 0 | 6 | 1,607 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 1,435,423 | 3,877.0879 | null | 11 | other | 35.296875 | 63 | 0.530884 | 0.33197 | 1 | 0 | 0 | no | null | null | no dnr | 6 | 58 | 10.5 | 72 | 24 | 36 | null | 2.199707 | 19.796875 | 2.099609 | 126 | null | null | null | null | null | null | null | 2.439941 |
503 | 55.13998 | 0 | female | 0 | 4 | 1,604 | COPD | COPD/CHF/Cirrhosis | 5 | null | null | 0 | 7,322 | 3,337.082 | null | 10 | white | 15.298828 | 25 | 0.931885 | 0.883911 | 1 | 1 | 0 | no | null | null | no dnr | 4 | 71 | 7.599609 | 84 | 20 | 36.79688 | 223.78125 | null | null | 0.699951 | 136 | 7.439453 | null | null | null | 1 | 5 | adl>=4 (>=5 if sur) | 5 |
504 | 30.69099 | 1 | male | 0 | 19 | 673 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 44 | 138,003 | 66,716.625 | null | 26 | white | 25.597656 | 33 | 0.733887 | 0.650879 | 9 | 0 | 0 | no | null | null | no dnr | 19 | 110 | 17.199219 | 150 | 45 | 38.69531 | 357.5 | null | null | 0.599976 | 135 | 7.479492 | null | null | null | null | null | null | 2.57959 |
505 | 47.34799 | 1 | female | 0 | 6 | 19 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | null | 37 | 23,807 | 11,111.2266 | null | 24 | white | 22.796875 | 26 | 0.790894 | 0.7229 | 1 | 0 | 0 | no | 0.98 | 0.9 | no dnr | 6 | 77 | 14.298828 | 100 | 45 | 38.09375 | 196.65625 | null | 0.599976 | 0.599976 | 143 | 7.469727 | null | null | null | null | null | <2 mo. follow-up | 3.479492 |
506 | 60.23297 | 1 | male | 0 | 9 | 17 | Lung Cancer | Cancer | 1 | null | null | 0 | 16,410 | 9,693.4141 | null | 11 | other | 18.296875 | 56 | 0.69397 | 0.403992 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 2 | 79 | 19.898438 | 160 | 16 | 36.39844 | 228.5625 | 4.199219 | 1.299805 | 1.799805 | 134 | 7.459961 | null | null | null | null | null | <2 mo. follow-up | 3.338867 |
507 | 37.08099 | 0 | male | 0 | 7 | 1,601 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 7,547 | 4,304.6484 | null | 6.5 | white | 24.097656 | 24 | 0.8479 | 0.75 | 1 | 0 | 0 | no | 0.95 | 0.5 | no dnr | 7 | 105 | 7.599609 | 100 | 22 | 38.79688 | null | null | 6.899414 | 0.599976 | 133 | null | null | null | null | null | null | null | 3.242188 |
508 | 63.25 | 0 | male | 0 | 5 | 1,599 | Lung Cancer | Cancer | 1 | 13 | $25-$50k | 0 | 15,400 | 7,650.8516 | null | 11 | asian | 5.699219 | 21 | 0.872925 | 0.713989 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 87 | 11.199219 | 100 | 30 | 38 | null | 4.599609 | 0.5 | 0.899902 | 134 | null | null | null | null | null | null | no(M2 and SIP pres) | 1.87085 |
509 | 51.87698 | 1 | male | 0 | 11 | 202 | Lung Cancer | Cancer | 1 | 16 | >$50k | 0 | 22,975 | 10,616.9688 | null | 13 | white | 23.699219 | 14 | 0.591919 | 0.272949 | 1 | 0 | 0 | metastatic | null | null | no dnr | 11 | 91 | 3.899902 | 100 | 20 | 36.59375 | 285.6875 | 2.899902 | 0.299988 | 0.899902 | 133 | 7.519531 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
510 | 69.50299 | 1 | male | 0 | 13 | 25 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 45,162 | 22,656.4219 | null | 18.5 | white | 30.699219 | 43 | 0.62793 | 0.44397 | 4 | 0 | 0 | no | null | null | no dnr | 13 | 53 | 14.599609 | 110 | 20 | 36.89844 | 306 | null | null | 1.699951 | 127 | 7.269531 | null | null | null | 0 | null | <2 mo. follow-up | 0.4948 |
511 | 84.43799 | 1 | male | 0 | 8 | 31 | CHF | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 25,793 | 11,553.2656 | null | 17.5 | white | 16.699219 | 35 | 0.799927 | 0.677979 | 1 | 0 | 0 | yes | 0.8 | 0.2 | no dnr | 8 | 60 | 4.199219 | 85 | 38 | 37.5 | 246.9375 | null | 0.299988 | 1 | 131 | 7.589844 | null | null | null | null | null | <2 mo. follow-up | 3.622559 |
512 | 46.60397 | 1 | male | 0 | 6 | 593 | Lung Cancer | Cancer | 1 | 16 | >$50k | 0 | 17,707 | 9,833.4844 | null | 9 | white | 19.097656 | 19 | 0.708984 | 0.426941 | 1 | 0 | 0 | metastatic | null | null | no dnr | 6 | 60 | 7.699219 | 134 | 22 | 38.79688 | null | null | null | 0.899902 | 135 | null | null | null | null | 1 | 2 | no(M2 and SIP pres) | 2 |
513 | 60.07397 | 1 | female | 1 | 4 | 4 | Lung Cancer | Cancer | 1 | null | null | 41 | 6,149 | 2,807.7559 | null | 11 | white | 31.5 | 22 | 0.146973 | 0.008999 | 1 | 0 | 0 | metastatic | 0.05 | 0.000125 | dnr after sadm | 2 | 107 | 10.898438 | 116 | 24 | 36 | 228 | 2.899902 | null | 0.399963 | 144 | 7.489258 | null | null | null | null | null | <2 mo. follow-up | 3.416992 |
514 | 62.27197 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 16 | null | 0 | 150,556 | 75,833.1875 | null | 38.5 | white | 32.195313 | 70 | 0.584961 | 0.475952 | 12 | 0 | 0 | no | null | null | dnr after sadm | 6 | 68 | 6.799805 | 140 | 36 | 38 | 369.5625 | 3.399902 | 6.099609 | 7.299805 | 132 | 7.5 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
515 | 48.353 | 1 | male | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | null | 100 | 565,876 | 341,404.25 | null | 59 | white | 75.1875 | 97 | 0 | 0 | 54 | 1 | 0 | no | null | null | dnr after sadm | 2 | 20 | 49.898438 | 135 | 24 | 36.29688 | 76 | 4.399414 | 24.097656 | 3.399902 | 149 | 7.239258 | null | null | null | null | null | <2 mo. follow-up | 2.887695 |
516 | 78.33795 | 1 | male | 1 | 4 | 4 | Coma | Coma | 0 | null | null | 100 | 31,356 | 14,755.6641 | null | 39 | white | 38.09375 | 65 | 0.001 | 0 | 1 | 0 | 0 | no | null | null | dnr after sadm | 4 | 50 | 6.599609 | 150 | 22 | 37.5 | 143.3125 | null | null | 2.099609 | 128 | 7.40918 | null | null | null | null | null | <2 mo. follow-up | 3.251465 |
517 | 58.14099 | 1 | female | 0 | 3 | 1,241 | CHF | COPD/CHF/Cirrhosis | 4 | null | null | 0 | 4,642 | 2,539.3711 | null | 5 | white | 17.398438 | 19 | 0.900879 | 0.833984 | 1 | 1 | 0 | no | null | null | no dnr | 3 | 117 | 9.099609 | 105 | 24 | 36.5 | 252.375 | null | null | 0.899902 | 140 | 7.289062 | null | null | null | null | null | null | 2.500488 |
518 | 60.87299 | 1 | female | 0 | 11 | 449 | CHF | COPD/CHF/Cirrhosis | 5 | 12 | under $11k | 0 | 29,509 | 15,321.5625 | null | 23.5 | black | 17.898438 | 20 | 0.891968 | 0.819946 | 1 | 1 | 0 | no | null | null | no dnr | 11 | 67 | 9.798828 | 75 | 20 | 36.29688 | null | null | 1.399902 | 1.199951 | 131 | null | null | null | null | null | null | no(M2 and SIP pres) | 3.648926 |
519 | 51.62198 | 1 | male | 1 | 4 | 4 | MOSF w/Malig | ARF/MOSF | 1 | 10 | null | 44 | 85,043 | 42,495 | null | 47 | black | 44.398438 | 111 | 0.009998 | 0.002 | 17 | 0 | 0 | yes | null | null | no dnr | 4 | 57 | 0.049995 | 145 | 40 | 40 | 178 | null | 2.199707 | 7.799805 | 133 | 7.289062 | null | null | null | null | null | <2 mo. follow-up | 2.771484 |
520 | 48.62399 | 1 | female | 0 | 42 | 138 | MOSF w/Malig | ARF/MOSF | 2 | 16 | $11-$25k | 0 | 95,852 | null | null | 14.75 | white | 20.5 | 42 | 0.72998 | 0.645996 | 1 | 0 | 0 | metastatic | 0.5 | 0.2 | dnr after sadm | 26 | 62 | 8.099609 | 110 | 20 | 37.5 | null | 2.399902 | 2 | 2.099609 | 141 | null | null | null | null | null | 6 | null | 6 |
521 | 29.63699 | 1 | male | 0 | 20 | 30 | Coma | Coma | 1 | 12 | null | 94 | 168,489 | null | null | 24.333328 | hispanic | 22.796875 | 20 | 0.458984 | 0.385986 | 7 | 0 | 0 | yes | 0.4 | 0.3 | no dnr | 20 | 67 | 17.398438 | 40 | 14 | 35.89844 | 230 | null | null | 0.899902 | 135 | 7.509766 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
522 | 54.146 | 1 | male | 0 | 11 | 824 | Colon Cancer | Cancer | 1 | 16 | >$50k | 0 | 44,109 | 24,268.8281 | null | 17 | white | 7 | 22 | 0.922974 | 0.820923 | 1 | 0 | 0 | metastatic | 0.95 | 0.75 | no dnr | 11 | 117 | 18.398438 | 90 | 14 | 37 | null | 5.099609 | 3 | 1 | 133 | null | null | null | null | null | null | null | 2.172363 |
523 | 68.16998 | 0 | female | 0 | 11 | 1,591 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 38,996 | 19,592.3438 | null | 13.5 | white | 22.097656 | 33 | 0.700928 | 0.537964 | 1 | 1 | 0 | no | null | null | no dnr | 11 | 97 | 19.398438 | 110 | 22 | 37 | 282.8125 | 1.899902 | 3.399902 | 0.799927 | 137 | 7.339844 | null | null | null | null | null | null | 3.621582 |
524 | 47.73398 | 1 | male | 0 | 10 | 806 | CHF | COPD/CHF/Cirrhosis | 2 | 15 | under $11k | 0 | 30,953 | null | null | 14.5 | black | 33.09375 | 32 | 0.744995 | 0.598999 | 1 | 0 | 0 | no | 0.75 | 0.7 | no dnr | 10 | 43 | 5.299805 | 90 | 22 | 36 | null | 3.699707 | 3.099609 | 1.199951 | 126 | null | null | null | null | 6 | null | no(M2 and SIP pres) | 4.527397 |
525 | 91.84399 | 1 | female | 1 | 4 | 4 | Coma | Coma | 0 | null | null | 100 | 11,415 | 5,410.4688 | null | 7 | white | 26.097656 | 49 | 0.017998 | 0.007 | 1 | 0 | 0 | no | null | null | dnr after sadm | 2 | 73 | 28.296875 | 100 | 36 | 35.29688 | 332 | 2.899902 | 0.5 | 1.699951 | 143 | 7.549805 | null | null | null | null | null | <2 mo. follow-up | 4.032227 |
526 | 59.39798 | 1 | male | 0 | 6 | 134 | Colon Cancer | Cancer | 1 | 16 | $25-$50k | 0 | 8,512 | 4,250.8945 | null | 14 | white | 15.298828 | 11 | 0.846924 | 0.662964 | 1 | 0 | 0 | metastatic | 0.9 | 0.4 | no dnr | 6 | 71 | 6.099609 | 60 | 22 | 37.79688 | null | 3.399902 | null | 0.899902 | 139 | null | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
527 | 49.59598 | 1 | female | 1 | 9 | 9 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 102,876 | null | null | 43.5 | null | 52.796875 | 85 | 0.168976 | 0.084991 | 2 | 0 | 0 | no | null | null | dnr after sadm | 9 | 50 | 15.199219 | 170 | 24 | 39.29688 | 65.32812 | 4.199219 | 24.199219 | 7.099609 | 143 | 7.479492 | null | null | null | null | null | <2 mo. follow-up | 2.527832 |
528 | 51.086 | 0 | female | 0 | 69 | 1,585 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 10 | $25-$50k | 26 | 480,519 | null | null | 37.5 | hispanic | 30.898438 | 51 | 0.599976 | 0.492981 | 5 | 0 | 0 | no | null | null | no dnr | 69 | 110 | 18.699219 | 130 | 20 | 39.19531 | 270 | 3.199707 | 11.5 | 1.5 | 150 | 7.519531 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
529 | 46.22598 | 0 | male | 0 | 46 | 1,585 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | under $11k | 0 | 349,052 | null | null | 30 | hispanic | 31.199219 | 33 | 0.783936 | 0.653931 | 1 | 1 | 0 | no | 0.5 | 0.5 | no dnr | 46 | 61 | 13.5 | 145 | 8 | 38.39844 | 155.09375 | 2.899902 | 1.399902 | 1 | 129 | 7.5 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
530 | 76.77197 | 0 | male | 0 | 19 | 1,584 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 92,775 | null | null | 23 | white | 22 | 36 | 0.755981 | 0.678955 | 5 | 0 | 0 | no | null | null | no dnr | 19 | 70 | 18.097656 | 60 | 20 | 38.79688 | 151.65625 | 2.299805 | null | 1.099854 | 133 | 7.5 | null | null | null | null | null | null | 2.277344 |
531 | 50.59497 | 1 | male | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $25-$50k | 100 | 93,265 | 49,813.9688 | null | 42 | hispanic | 53.296875 | 118 | 0 | 0 | 31 | 1 | 0 | no | null | null | no dnr | 5 | 37 | 17.699219 | 75 | 40 | 36.89844 | 143 | 1.5 | 21 | 3 | 134 | 7.079102 | null | null | null | null | null | <2 mo. follow-up | 4.154297 |
532 | 60.56897 | 0 | male | 0 | 13 | 1,584 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 26 | 75,752 | 36,327.7812 | null | 15 | white | 17.5 | 17 | 0.819946 | 0.758911 | 4 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 13 | 60 | 13.099609 | 72 | 10 | 38.39844 | 205.4375 | null | null | 0.699951 | 135 | 7.449219 | null | null | null | null | null | null | 3.694824 |
533 | 43.21399 | 1 | female | 1 | 6 | 6 | MOSF w/Malig | ARF/MOSF | 2 | null | null | 26 | 43,810 | 18,669.25 | null | 26 | null | 30.5 | 59 | 0.428955 | 0.30896 | 2 | 0 | 0 | yes | 0.1 | 0.001 | dnr after sadm | 6 | 57 | 7.699219 | 120 | 36 | 39.19531 | 150 | null | null | 1.899902 | 134 | 7.5 | null | null | null | null | null | <2 mo. follow-up | 2.734863 |
534 | 82.63098 | 1 | male | 0 | 5 | 30 | CHF | COPD/CHF/Cirrhosis | 2 | 16 | null | 0 | 7,920 | 4,590.6367 | null | 15 | white | 23 | 35 | 0.754883 | 0.612915 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 77 | 19.398438 | 70 | 22 | 36.39844 | null | null | null | 2.299805 | 132 | null | null | null | null | null | 2 | <2 mo. follow-up | 2 |
535 | 80.23798 | 1 | female | 0 | 9 | 258 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 44 | 43,960 | 22,739.5156 | null | 25 | white | 21.5 | 21 | 0.643921 | 0.542969 | 1 | 0 | 0 | no | 0.6 | 0.6 | no dnr | 9 | 113 | 15 | 60 | 10 | 37.89844 | 142.5 | null | null | 1.099854 | 136 | 7.459961 | null | null | null | null | 2 | adl>=4 (>=5 if sur) | 2 |
536 | 26.023 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 14 | under $11k | 44 | 166,772 | 82,111.625 | null | 47 | hispanic | 52.796875 | 62 | 0.026997 | 0.007 | 28 | 0 | 0 | yes | 0.3 | 0.2 | dnr after sadm | 6 | 40 | 3.299805 | 125 | 32 | 36 | 158 | null | null | 2.899902 | 130 | 7.319336 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
537 | 22.72699 | 0 | female | 0 | 7 | 1,579 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | >$50k | 0 | 23,778 | 10,942.8516 | null | 12 | black | 26.398438 | 28 | 0.876953 | 0.833984 | 3 | 0 | 0 | no | null | null | no dnr | 7 | 99 | 6.799805 | 112 | 40 | 38.5 | 140.8125 | null | null | 0.799927 | 134 | 7.469727 | null | null | null | 2 | 0 | null | 0 |
538 | 52.67599 | 1 | male | 0 | 9 | 544 | Lung Cancer | Cancer | 1 | 17 | >$50k | 0 | 22,661 | 12,761.7266 | null | 14.5 | white | 20.398438 | 16 | 0.666992 | 0.366943 | 1 | 0 | 0 | metastatic | 0.95 | 0.7 | no dnr | 9 | 104 | 37.296875 | 78 | 16 | 37.79688 | null | null | null | 0.899902 | 128 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
539 | 64.11798 | 1 | female | 0 | 8 | 183 | Lung Cancer | Cancer | 3 | null | null | 0 | 12,023 | 5,635.4844 | null | 8 | black | 4 | 26 | 0.887939 | 0.745972 | 1 | 0 | 0 | metastatic | 1 | 0.5 | no dnr | 8 | 109 | 10.5 | 78 | 16 | 36.39844 | null | 4.699219 | 0.699951 | 1.299805 | 134 | null | null | null | null | null | null | null | 2.819336 |
540 | 36.211 | 1 | female | 1 | 17 | 17 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $11-$25k | 44 | 374,053 | 180,218.625 | null | 44.666657 | black | 40.09375 | 65 | 0.208984 | 0.113998 | 31 | 0 | 0 | yes | 0.5 | 0.125 | no dnr | 17 | 130 | 7.399414 | 125 | 14 | 37.5 | 87.5 | 3.299805 | 18.597656 | 2.5 | 142 | 7.439453 | null | null | null | null | null | <2 mo. follow-up | 3.503418 |
541 | 29.588 | 0 | male | 0 | 93 | 1,578 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 12 | $11-$25k | 41 | 563,075 | null | null | 37.25 | black | 38.5 | 54 | 0.485962 | 0.367981 | 3 | 0 | 0 | no | null | null | no dnr | 93 | 115 | 1.899902 | 120 | 38 | 35.79688 | 305 | null | 3.399902 | 5.599609 | 137 | 7.389648 | null | null | null | null | null | adl>=4 (>=5 if sur) | 3.710449 |
542 | 63.95599 | 1 | male | 1 | 21 | 21 | CHF | COPD/CHF/Cirrhosis | 2 | 9 | >$50k | 0 | 68,631 | null | null | 20 | hispanic | 26.699219 | 35 | 0.777954 | 0.645996 | 1 | 0 | 0 | no | 0.8 | 0.6 | dnr after sadm | 19 | 68 | 8.099609 | 100 | 16 | 36 | null | null | 2.199707 | 1.599854 | 125 | null | null | null | null | 5 | null | <2 mo. follow-up | 3.855299 |
543 | 70.90997 | 1 | male | 1 | 8 | 8 | CHF | COPD/CHF/Cirrhosis | 4 | 18 | null | 0 | 13,400 | 7,033.3555 | null | 9 | white | 14.599609 | 35 | 0.896973 | 0.826904 | 1 | 1 | 1 | no | null | null | no dnr | 8 | 93 | 10.099609 | 72 | 20 | 36 | null | 4.699219 | null | 2.5 | 138 | null | null | null | null | 0 | null | <2 mo. follow-up | 0.4948 |
544 | 66.63098 | 1 | female | 0 | 10 | 229 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 10 | >$50k | 0 | 14,175 | 7,477.4492 | null | 18.5 | white | 24.199219 | 33 | 0.599976 | 0.409973 | 1 | 0 | 0 | yes | 0.85 | 0.6 | no dnr | 10 | 80 | 5.699219 | 110 | 22 | 36 | null | 3 | 2.599609 | 2 | 140 | null | null | null | null | null | null | no(M2 and SIP pres) | 3.280762 |
545 | 77.17499 | 1 | female | 0 | 9 | 183 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 14,976 | 7,870.4492 | null | 7 | white | 20.597656 | 25 | 0.638916 | 0.458984 | 2 | 0 | 0 | no | 0.9 | 0.5 | no dnr | 9 | 82 | 7.799805 | 72 | 20 | 36 | null | null | 6.299805 | 1.199951 | 138 | null | null | null | null | null | null | null | 3.434082 |
546 | 60.54498 | 1 | male | 1 | 16 | 16 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | $25-$50k | 26 | 283,844 | 136,717.875 | null | 41 | hispanic | 29.097656 | 71 | 0.550903 | 0.437988 | 16 | 1 | 0 | no | 0.75 | 0.75 | dnr after sadm | 14 | 107 | 10.599609 | 125 | 35 | 38.5 | 202 | 1.699951 | 9.298828 | 1.199951 | 143 | 7.389648 | null | null | null | null | null | <2 mo. follow-up | 2.759277 |
547 | 76.56696 | 1 | male | 1 | 29 | 29 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | null | 26 | 308,455 | null | null | 40.25 | white | 28.699219 | 66 | 0.376953 | 0.258972 | 11 | 1 | 0 | yes | 0.2 | 0.1 | dnr after sadm | 27 | 108 | 10.398438 | 145 | 32 | 38.29688 | 188.5625 | 1.699951 | 7.099609 | 1.199951 | 136 | 7.489258 | null | null | null | null | null | <2 mo. follow-up | 3.448242 |
548 | 76.63495 | 1 | male | 0 | 25 | 59 | CHF | COPD/CHF/Cirrhosis | 2 | 11 | $11-$25k | 0 | 63,938 | null | null | 14.25 | white | 31 | 56 | 0.625 | 0.440979 | 1 | 0 | 0 | no | 0.8 | 0.5 | no dnr | 25 | 47 | 14.398438 | 95 | 30 | 37.5 | 184 | null | null | 1.599854 | 134 | 7.459961 | null | null | null | 0 | 1 | <2 mo. follow-up | 1 |
549 | 51.20099 | 1 | male | 1 | 8 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 41,580 | 19,861.5625 | null | 29 | asian | 30 | 60 | 0.765991 | 0.691895 | 1 | 1 | 0 | no | 0.5 | 0.2 | dnr after sadm | 6 | 68 | 22.796875 | 110 | 24 | 37.89844 | 212.5 | 1.699951 | 4.299805 | 3.199707 | 133 | 7.349609 | null | null | null | null | null | <2 mo. follow-up | 2.691406 |
550 | 20.24399 | 1 | male | 0 | 9 | 144 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 11,528 | 6,997.7109 | null | 8.5 | hispanic | 21.597656 | 25 | 0.938965 | 0.895996 | 1 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 9 | 60 | 8.699219 | 70 | 24 | 36 | null | null | null | 1.599854 | 128 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.849121 |
551 | 69.47296 | 0 | female | 0 | 36 | 1,573 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 12 | >$50k | 0 | 151,788 | null | null | 16 | white | 30.398438 | 45 | 0.483948 | 0.282959 | 1 | 0 | 0 | no | null | null | no dnr | 36 | 71 | 10.199219 | 68 | 20 | 36.80469 | null | 2.599609 | 18.597656 | 1.599854 | 126 | null | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
552 | 76.76099 | 1 | female | 1 | 8 | 8 | Lung Cancer | Cancer | 2 | null | null | 0 | 18,406 | 9,426.6562 | null | 14 | white | 21.5 | 20 | 0.571899 | 0.250977 | 1 | 1 | 0 | metastatic | null | null | dnr after sadm | 5 | 67 | 11.398438 | 92 | 20 | 36.39844 | 368 | null | null | 0.599976 | 130 | 7.429688 | null | null | null | null | null | <2 mo. follow-up | 3.887207 |
553 | 24.56699 | 0 | female | 0 | 66 | 1,571 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 0 | 392,270 | null | null | 29.75 | hispanic | 28.296875 | 55 | 0.853882 | 0.803955 | 3 | 0 | 0 | no | 0.2 | 0.008 | no dnr | 66 | 65 | 10.199219 | 130 | 32 | 38.5 | 166.65625 | null | 0.799927 | 8.798828 | 137 | 7.369141 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
554 | 53.62097 | 0 | female | 0 | 10 | 1,572 | Colon Cancer | Cancer | 1 | null | null | 0 | 28,094 | 14,153.4141 | null | 18 | white | 15.699219 | 4 | 0.851929 | 0.672974 | 1 | 0 | 0 | metastatic | null | null | no dnr | 10 | 80 | 9.699219 | 105 | 22 | 38.19531 | 476.1875 | null | null | null | 140 | 7.40918 | null | null | null | null | null | null | 2.598145 |
555 | 78.88794 | 1 | male | 1 | 7 | 7 | MOSF w/Malig | ARF/MOSF | 1 | 13 | >$50k | 44 | 88,377 | 44,241.8438 | null | 26 | white | 22 | 37 | 0.379944 | 0.260986 | 5 | 0 | 0 | metastatic | 0 | 0 | dnr after sadm | 4 | 73 | 7.199219 | 105 | 25 | 38.59375 | 198 | null | null | 1.699951 | 147 | 7.5 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
556 | 68.40497 | 1 | female | 0 | 14 | 330 | Lung Cancer | Cancer | 1 | 12 | null | 0 | 32,994 | 16,753.8906 | null | 15.666664 | white | 18.296875 | 32 | 0.67395 | 0.375977 | 1 | 0 | 0 | metastatic | 0.2 | 0 | no dnr | 14 | 62 | 7.899414 | 75 | 30 | 36.59375 | 257.125 | null | null | 1.799805 | 136 | 7.459961 | null | null | null | 0 | null | null | 0.4948 |
557 | 74.94299 | 1 | male | 1 | 45 | 45 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 61 | 345,855 | 174,356.5 | null | 38 | black | 21.597656 | 30 | 0.55896 | 0.445984 | 3 | 1 | 0 | no | null | null | dnr after sadm | 43 | 107 | 22.5 | 105 | 30 | 38.09375 | 300 | null | 1.099854 | 1.099854 | 131 | 7.519531 | null | null | null | null | null | <2 mo. follow-up | 3.674316 |
558 | 72.98798 | 1 | female | 1 | 4 | 4 | Coma | Coma | 1 | 12 | null | 100 | 16,404 | 8,632.5156 | null | 22 | asian | 31.597656 | 58 | 0.025997 | 0.011 | 1 | 0 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 3 | 45 | 28.398438 | 185 | 36 | 38.29688 | 423.3125 | 3.399902 | 0.599976 | 1 | 141 | 7.469727 | null | null | null | null | null | <2 mo. follow-up | 3.219727 |
559 | 50.28897 | 1 | female | 0 | 4 | 67 | Colon Cancer | Cancer | 1 | null | null | 0 | 6,673 | 3,496.5977 | null | 10 | white | 13.599609 | 16 | 0.87793 | 0.723999 | 1 | 0 | 0 | metastatic | null | null | no dnr | 4 | 83 | 9.398438 | 84 | 20 | 38 | null | null | 0.599976 | 1.399902 | 136 | null | null | null | null | null | null | null | 1.871582 |
560 | 87.48297 | 1 | female | 0 | 4 | 636 | CHF | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 4,969 | 2,898.3867 | null | 5 | white | 17.5 | 18 | 0.81897 | 0.705933 | 1 | 0 | 0 | no | null | null | dnr after sadm | 1 | 83 | 13.398438 | 60 | 18 | 36.79688 | null | null | null | 1 | 134 | null | null | null | null | null | null | null | 2.849121 |
561 | 25.95799 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | >$50k | 0 | 73,645 | 34,122.2188 | null | 24 | white | 52 | 76 | 0.186981 | 0.097992 | 11 | 0 | 0 | yes | 0.05 | 0.000125 | dnr after sadm | 4 | 123 | 2.199707 | 115 | 32 | 35.29688 | 56 | null | 10.199219 | 1.599854 | 129 | 7.449219 | null | null | null | null | null | <2 mo. follow-up | 2.412598 |
562 | 78.88794 | 0 | female | 0 | 48 | 1,560 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 7 | null | 0 | 198,860 | null | null | 22.75 | white | 29.5 | 28 | 0.566895 | 0.454956 | 8 | 0 | 0 | no | null | null | no dnr | 48 | 55 | 19.398438 | 90 | 14 | 38.79688 | 160 | 2.699707 | null | 0.5 | 128 | 7.5 | null | null | null | null | null | no(M2 and SIP pres) | 2.538086 |
563 | 52.30099 | 1 | male | 0 | 4 | 161 | Colon Cancer | Cancer | 1 | null | null | 0 | 4,510 | 2,831.8672 | null | 9 | null | 4 | 15 | 0.940918 | 0.858887 | 1 | 0 | 0 | metastatic | null | null | no dnr | 4 | 87 | 7.699219 | 62 | 20 | 36.19531 | null | 4.699219 | 0.5 | 1 | 134 | null | null | null | null | null | null | null | 1.562012 |
564 | 49.08698 | 1 | male | 1 | 16 | 16 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 14 | null | 37 | 176,752 | 82,695.1875 | null | 30.333328 | white | 51.5 | 106 | 0.030998 | 0.007999 | 18 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 2 | 48 | 37.59375 | 145 | 28 | 38.29688 | 118 | 4.799805 | 19.296875 | 4.699219 | 142 | 7.389648 | null | null | null | null | null | <2 mo. follow-up | 3.022461 |
565 | 54.48599 | 0 | female | 0 | 11 | 1,558 | Colon Cancer | Cancer | 1 | 15 | null | 0 | 37,609 | 18,547.4219 | null | 26.5 | white | 23.597656 | 32 | 0.734985 | 0.465942 | 1 | 0 | 0 | metastatic | 0.99 | 0.95 | no dnr | 11 | 73 | 12.798828 | 120 | 30 | 37 | 388.5625 | 4 | 1 | 1.099854 | 133 | 7.329102 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
566 | 32.70599 | 1 | female | 1 | 103 | 103 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 21 | null | 55 | 1,233,213 | null | null | 45 | white | 34 | 52 | 0.564941 | 0.453979 | 1 | 0 | 0 | no | null | null | no dnr | 103 | 122 | 7.299805 | 105 | 15 | 36.19531 | 192.5 | 4 | 9.5 | 3.799805 | 149 | 7.449219 | null | null | null | null | 3 | null | 3 |
567 | 40.46799 | 1 | female | 0 | 46 | 265 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | >$50k | 26 | 289,233 | null | null | 36.75 | white | 37.195313 | 39 | 0.480957 | 0.362976 | 8 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 46 | 42 | 12.898438 | 125 | 34 | 38.29688 | 155 | 2.899902 | 0.599976 | 0.799927 | 135 | 7.509766 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
568 | 76.47095 | 1 | male | 1 | 24 | 24 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | >$50k | 26 | 203,430 | 96,371.6875 | null | 44.666657 | asian | 39.898438 | 68 | 0.156982 | 0.076996 | 9 | 1 | 0 | no | 0.5 | 0.1 | dnr after sadm | 9 | 67 | 14.398438 | 145 | 10 | 39 | 98.32812 | 2.199707 | 15.298828 | 1.5 | 153 | 7.489258 | null | null | null | null | null | <2 mo. follow-up | 3.045898 |
569 | 64.20496 | 1 | female | 1 | 14 | 14 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 12 | >$50k | 55 | 103,876 | 48,555.0938 | null | 30 | hispanic | 34.796875 | 60 | 0.141998 | 0.032997 | 1 | 0 | 0 | no | 0.2 | 0.75 | dnr after sadm | 13 | 52 | 17.597656 | 110 | 38 | 36 | 165 | 2.399902 | 2.699707 | 1.399902 | 135 | 7.459961 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
570 | 56.07397 | 0 | female | 0 | 25 | 1,552 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | $11-$25k | 26 | 131,009 | 60,624 | null | 21.75 | white | 45.695313 | 68 | 0.123993 | 0.054993 | 14 | 0 | 0 | no | null | null | no dnr | 25 | 40 | 8.599609 | 150 | 42 | 36.39844 | 166 | 3.299805 | 5.699219 | 1.5 | 149 | 7.399414 | null | null | null | null | 4 | SIP>=30 | 4 |
571 | 73.01794 | 0 | female | 0 | 21 | 1,551 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | $25-$50k | 0 | 57,560 | 28,266.1094 | null | 16.666656 | hispanic | 24.199219 | 17 | 0.775879 | 0.703979 | 1 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 21 | 73 | 13.298828 | 65 | 16 | 38.39844 | 390 | null | null | 1 | 120 | 7.439453 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
572 | 75.50195 | 0 | female | 0 | 13 | 1,551 | Colon Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 14,005 | 7,870.8984 | null | 9 | white | 15.699219 | 15 | 0.814941 | 0.602905 | 1 | 0 | 0 | metastatic | 1 | 1 | no dnr | 13 | 104 | 12.898438 | 70 | 22 | 36.39844 | null | null | 0.799927 | 1 | 139 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
573 | 66.77594 | 0 | female | 0 | 12 | 1,551 | Colon Cancer | Cancer | 1 | null | null | 26 | 46,753 | 22,527.5625 | null | 14 | white | 5.799805 | 25 | 0.885986 | 0.741943 | 1 | 0 | 0 | metastatic | null | null | no dnr | 12 | 73 | 15.298828 | 105 | 10 | 38 | 223.3125 | 2.199707 | 0.199982 | 0.699951 | 136 | 7.40918 | null | null | null | null | null | null | 2.353027 |
574 | 52.30698 | 0 | male | 0 | 8 | 1,548 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $25-$50k | 26 | 54,390 | 26,411.8438 | null | 15.5 | black | 26.398438 | 42 | 0.696899 | 0.605957 | 5 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 8 | 113 | 14.398438 | 105 | 37 | 38.29688 | 245.6875 | 2.399902 | 6 | 1.299805 | 132 | 7.459961 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
575 | 50.17099 | 0 | female | 0 | 6 | 1,545 | Lung Cancer | Cancer | 1 | 12 | >$50k | 0 | 13,399 | 7,692.7422 | null | 12 | white | 19.699219 | 15 | 0.688965 | 0.397949 | 1 | 0 | 0 | metastatic | null | null | no dnr | 6 | 84 | null | 108 | 30 | 36.19531 | null | null | null | null | 140 | null | null | null | null | 0 | null | null | 0.4948 |
576 | 47.18997 | 1 | female | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 160,900 | 86,296.3125 | null | 43 | other | 39.398438 | 68 | 0.546997 | 0.432983 | 3 | 0 | 0 | no | null | null | no dnr | 7 | 60 | 26.097656 | 140 | 39 | 37 | 154.28125 | null | 7.899414 | 2.199707 | 148 | 7.429688 | null | null | null | null | null | <2 mo. follow-up | 2.745606 |
577 | 55.25497 | 1 | female | 1 | 7 | 7 | Lung Cancer | Cancer | 1 | null | null | 37 | 13,593 | 6,582.4961 | null | 14 | black | 20.5 | 25 | 0.491943 | 0.171997 | 1 | 0 | 0 | metastatic | 0 | 0 | dnr after sadm | 4 | 63 | 9.798828 | 120 | 28 | 38 | null | null | 0.899902 | 0.699951 | 142 | null | null | null | null | null | null | <2 mo. follow-up | 4.005859 |
578 | 59.36798 | 0 | male | 0 | 7 | 1,545 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | >$50k | 0 | 15,494 | 7,495.375 | null | 15 | white | 22.296875 | 35 | 0.852905 | 0.757935 | 1 | 0 | 0 | no | null | null | no dnr | 7 | 62 | 5.899414 | 145 | 24 | 36.5 | 440 | null | 0.699951 | 1.299805 | 131 | 7.549805 | null | null | null | null | 5 | null | 5 |
579 | 63.22498 | 1 | male | 0 | 13 | 95 | Colon Cancer | Cancer | 1 | null | null | 0 | 34,247 | 17,673.3125 | null | 25 | null | 7.299805 | 12 | 0.91394 | 0.799927 | 1 | 0 | 0 | metastatic | 0.9 | 0.6 | no dnr | 13 | 87 | 10 | 105 | 22 | 38 | null | 4.399414 | 0.399963 | 1 | 132 | null | null | null | null | null | null | null | 2.176758 |
580 | 54.69699 | 1 | male | 1 | 4 | 4 | MOSF w/Malig | ARF/MOSF | 1 | 18 | >$50k | 26 | 168,940 | 85,338.75 | null | 29 | white | 49.5 | 67 | 0.003 | 0 | 56 | 0 | 0 | yes | 0.05 | 0.000125 | dnr after sadm | 4 | 82 | 0.599976 | 115 | 34 | 36.5 | 171.40625 | 4.199219 | 26.699219 | 7.299805 | 151 | 7.419922 | null | null | null | null | null | <2 mo. follow-up | 2.468262 |
581 | 75.66095 | 0 | male | 0 | 6 | 1,542 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 16,067 | 8,125.9375 | null | 25 | white | 23 | 42 | 0.785889 | 0.656982 | 1 | 0 | 0 | no | 0.95 | 0.5 | no dnr | 6 | 55 | 9.898438 | 70 | 22 | 36.69531 | null | 3.599609 | 1 | 2.599609 | 135 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.421875 |
582 | 65.09198 | 1 | female | 0 | 17 | 203 | Colon Cancer | Cancer | 1 | 12 | >$50k | 26 | 56,695 | 29,327 | null | 21 | white | 8.398438 | 23 | 0.863892 | 0.696899 | 1 | 0 | 0 | metastatic | 0.95 | 0.8 | no dnr | 17 | 120 | 6.799805 | 100 | 28 | 37.5 | 182 | 4.399414 | 0.299988 | 1 | 139 | 7.359375 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
583 | 60.55298 | 1 | male | 0 | 5 | 297 | Lung Cancer | Cancer | 1 | null | null | 0 | 5,619 | 3,247.3672 | null | 10 | white | 3.599609 | 11 | 0.894897 | 0.758911 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 83 | 4.5 | 78 | 20 | 36.89844 | null | 4.299805 | 0.299988 | 1.099854 | 139 | null | null | null | null | null | null | null | 1.7854 |
584 | 30.015 | 1 | male | 0 | 99 | 635 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 55 | 871,855 | null | null | 27.75 | white | 35.09375 | 64 | 0.431946 | 0.311951 | 23 | 0 | 0 | no | null | null | no dnr | 99 | 58 | 11.298828 | 120 | 6 | 38.39844 | 290 | 3.699707 | 16.699219 | 5.399414 | 141 | 7.419922 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
585 | 35.92899 | 1 | male | 1 | 20 | 20 | Colon Cancer | Cancer | 1 | null | null | 0 | 39,582 | 21,738.4375 | null | 7.666664 | white | 16.097656 | 26 | 0.872925 | 0.714966 | 1 | 0 | 0 | metastatic | 0.5 | 0.05 | dnr after sadm | 16 | 85 | 5.099609 | 64 | 10 | 36.19531 | null | 4.099609 | null | 1.799805 | 131 | null | null | null | null | null | null | <2 mo. follow-up | 2.546875 |
586 | 54.84998 | 1 | female | 0 | 4 | 95 | Lung Cancer | Cancer | 1 | 16 | $11-$25k | 26 | 3,278 | 2,616.9863 | null | 4 | black | 16.097656 | 13 | 0.656982 | 0.352966 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 1 | 100 | 7.899414 | 80 | 18 | 36 | null | null | null | 0.799927 | 136 | null | null | null | null | 3 | 1 | SIP>=30 | 1 |
587 | 90.32196 | 1 | female | 0 | 27 | 50 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | null | 26 | 106,419 | 50,455.5938 | null | 18 | white | 20.597656 | 30 | 0.643921 | 0.542969 | 3 | 0 | 1 | no | 0.2 | 0.15 | dnr after sadm | 7 | 68 | 11.099609 | 45 | 12 | 37 | 237.5 | null | null | 1 | 133 | 7.459961 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
588 | 84.33899 | 1 | female | 1 | 24 | 24 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 26 | 271,224 | 129,202.75 | null | 23 | white | 30.898438 | 50 | 0.312988 | 0.199982 | 45 | 0 | 0 | no | 0.3 | 0.1 | dnr after sadm | 18 | 110 | 12.798828 | 70 | 16 | 35.89844 | 134.6875 | null | null | 5 | 134 | 7.5 | null | null | null | null | null | <2 mo. follow-up | 3.480469 |
589 | 57.23999 | 0 | male | 0 | 50 | 1,525 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | 19 | >$50k | 44 | 410,745 | 212,786.5 | null | 41 | white | 38.5 | 64 | 0.161987 | 0.042 | 1 | 0 | 0 | no | 0.6 | 0.6 | no dnr | 50 | 57 | 2.799805 | 110 | 9 | 34 | 257.125 | 3 | 7 | 2.699707 | 150 | 7.459961 | null | null | null | null | null | no(M2 and SIP pres) | 3.99707 |
590 | 38.80399 | 0 | female | 0 | 22 | 1,524 | CHF | COPD/CHF/Cirrhosis | 3 | 14 | $25-$50k | 0 | 133,255 | 76,584.625 | null | 26.666656 | white | 24.296875 | 33 | 0.824951 | 0.715942 | 1 | 0 | 0 | metastatic | null | null | no dnr | 22 | 60 | 6.899414 | 120 | 16 | 36.09375 | null | 3.399902 | 0.299988 | 2.199707 | 137 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
591 | 72.46497 | 1 | female | 0 | 5 | 54 | Lung Cancer | Cancer | 2 | null | null | 0 | 5,552 | 3,448.8789 | null | 10 | black | 17.398438 | 12 | 0.680908 | 0.385986 | 1 | 1 | 0 | metastatic | null | null | no dnr | 5 | 83 | 13 | 74 | 20 | 36.19531 | null | null | null | 0.799927 | 135 | null | null | null | null | null | null | <2 mo. follow-up | 2.616699 |
592 | 92.60199 | 1 | female | 0 | 16 | 54 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 13 | $25-$50k | 44 | 50,810 | 24,484.25 | null | 18.333328 | white | 23.699219 | 33 | 0.511963 | 0.395996 | 1 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 16 | 120 | 22.296875 | 115 | 24 | 36 | 388.5625 | 2.199707 | 0.899902 | 1.599854 | 141 | 7.429688 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
593 | 59.69299 | 1 | female | 1 | 5 | 5 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 44 | 71,936 | 35,045.9688 | null | 22 | white | 36.398438 | 45 | 0.042999 | 0.012999 | 15 | 0 | 0 | metastatic | 0.1 | 0.001 | dnr after sadm | 2 | 73 | 4.299805 | 128 | 8 | 38.39844 | 95 | null | null | 1.699951 | 155 | 7.369141 | null | null | null | null | null | <2 mo. follow-up | 3.4375 |
594 | 52.767 | 1 | male | 0 | 12 | 217 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 12 | >$50k | 0 | 43,499 | 20,655.6406 | null | 12.5 | white | 21.398438 | 30 | 0.809937 | 0.691895 | 1 | 0 | 0 | no | 0.6 | 0.7 | no dnr | 12 | 77 | 2.699707 | 64 | 22 | 36.79688 | null | 2.699707 | 5 | 0.899902 | 130 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
595 | 54.97098 | 0 | female | 0 | 5 | 1,515 | COPD | COPD/CHF/Cirrhosis | 3 | 8 | >$50k | 0 | 4,936 | 3,261.3223 | null | 9 | black | 15.5 | 15 | 0.930908 | 0.882935 | 1 | 1 | 0 | no | null | null | no dnr | 5 | 93 | 10.398438 | 88 | 24 | 36.39844 | 272 | null | 0.299988 | 1.099854 | 135 | 7.389648 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
596 | 62.35699 | 0 | male | 0 | 26 | 1,514 | Coma | Coma | 0 | null | null | 44 | 58,097 | 34,727.1562 | null | 10.25 | null | 20.5 | 30 | 0.609985 | 0.546997 | 1 | 0 | 0 | no | null | null | no dnr | 26 | 130 | 12.199219 | 110 | 30 | 37 | 260 | null | 0.5 | 0.899902 | 146 | 7.579102 | null | null | null | null | null | null | 2.039063 |
597 | 82.01196 | 1 | female | 0 | 18 | 27 | COPD | COPD/CHF/Cirrhosis | 2 | 11 | $11-$25k | 0 | 45,384 | 20,617.7188 | null | 12 | white | 28.398438 | 59 | 0.594971 | 0.403992 | 1 | 0 | 0 | no | null | null | no dnr | 18 | 63 | 19.398438 | 110 | 32 | 36.29688 | 160.6875 | 3.899902 | 0.199982 | 2 | 153 | 7.369141 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
598 | 53.46997 | 1 | female | 0 | 11 | 465 | CHF | COPD/CHF/Cirrhosis | 3 | 9 | under $11k | 0 | 23,440 | 11,864.6953 | null | 8.5 | white | 23.796875 | 34 | 0.85498 | 0.759888 | 1 | 0 | 0 | no | 0.5 | 0.2 | no dnr | 11 | 77 | 11.699219 | 50 | 26 | 36.89844 | 360 | null | 0.399963 | 2.5 | 140 | 7.439453 | null | null | null | 2 | 3 | no(M2 and SIP pres) | 3 |
599 | 21.092 | 1 | male | 1 | 6 | 6 | Coma | Coma | 0 | 12 | >$50k | 89 | 91,295 | 43,409.4062 | null | 36 | white | 31.597656 | 51 | 0.370972 | 0.296997 | 16 | 0 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 3 | 57 | 26.699219 | 130 | 14 | 38.89844 | 463.3125 | null | 12.5 | 1.099854 | 150 | 7.429688 | null | null | null | null | null | <2 mo. follow-up | 2.537598 |
600 | 19.866 | 1 | female | 0 | 22 | 145 | CHF | COPD/CHF/Cirrhosis | 1 | 11 | null | 0 | 120,028 | 62,699.75 | null | 22.666656 | black | 37.195313 | 41 | 0.80188 | 0.679932 | 1 | 0 | 0 | no | null | null | no dnr | 22 | 47 | 11.599609 | 120 | 28 | 38 | null | 3.199707 | 3.299805 | 0.799927 | 128 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |